ATE346150T1 - Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen - Google Patents
Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungenInfo
- Publication number
- ATE346150T1 ATE346150T1 AT99922714T AT99922714T ATE346150T1 AT E346150 T1 ATE346150 T1 AT E346150T1 AT 99922714 T AT99922714 T AT 99922714T AT 99922714 T AT99922714 T AT 99922714T AT E346150 T1 ATE346150 T1 AT E346150T1
- Authority
- AT
- Austria
- Prior art keywords
- relates
- sh3d1a
- disorders
- gene
- leukemia
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000032839 leukemia Diseases 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 230000002071 myeloproliferative effect Effects 0.000 title 1
- 101001056724 Homo sapiens Intersectin-1 Proteins 0.000 abstract 3
- 208000018706 hematopoietic system disease Diseases 0.000 abstract 2
- 238000012216 screening Methods 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 201000010374 Down Syndrome Diseases 0.000 abstract 1
- 102100025494 Intersectin-1 Human genes 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000013544 Platelet disease Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8200798P | 1998-04-16 | 1998-04-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346150T1 true ATE346150T1 (de) | 2006-12-15 |
Family
ID=22168041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99922714T ATE346150T1 (de) | 1998-04-16 | 1999-04-16 | Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1071774B1 (de) |
JP (1) | JP2002511267A (de) |
AT (1) | ATE346150T1 (de) |
DE (1) | DE69934107D1 (de) |
WO (1) | WO1999053062A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1922301A (en) * | 1999-11-17 | 2001-05-30 | Nyxis Neurotherapies, Inc. | Differential gene expression in cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378809A (en) * | 1992-08-25 | 1995-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | Polynucleotides and substrate for the epidermal growth factor receptor kinase (eps8) |
JPH11509172A (ja) * | 1995-04-07 | 1999-08-17 | サイトジェン・コーポレーション | 目的の機能ドメインを有するポリペプチドおよびそれの同定および利用法 |
AU3695099A (en) * | 1998-04-27 | 1999-11-16 | Hsc Research And Development Limited Partnership | Ese genes and proteins |
-
1999
- 1999-04-16 DE DE69934107T patent/DE69934107D1/de not_active Expired - Lifetime
- 1999-04-16 AT AT99922714T patent/ATE346150T1/de not_active IP Right Cessation
- 1999-04-16 WO PCT/US1999/008371 patent/WO1999053062A2/en active IP Right Grant
- 1999-04-16 JP JP2000543610A patent/JP2002511267A/ja active Pending
- 1999-04-16 EP EP99922714A patent/EP1071774B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1071774B1 (de) | 2006-11-22 |
WO1999053062A2 (en) | 1999-10-21 |
WO1999053062A3 (en) | 2000-04-20 |
JP2002511267A (ja) | 2002-04-16 |
EP1071774A2 (de) | 2001-01-31 |
DE69934107D1 (de) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kainz et al. | Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t (15; 17), t (8; 21) or inv (16) | |
NO982785D0 (no) | Kromosom 13-koblet brystkreftmottagelighetsgen | |
WO1996005306A3 (en) | In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene | |
CA2196795A1 (en) | Method for diagnosing a predisposition for breast and ovarian cancer | |
WO2004011625A3 (en) | Polymorphisms for predicting disease and treatment outcome | |
Borcherding et al. | A transcriptomic map of murine and human alopecia areata | |
Hoshino et al. | X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia | |
ATE122727T1 (de) | Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna- sequenzen in menschlichen zellen enthalten. | |
ATE346150T1 (de) | Isolierte sh3 gene, die mit myeloproliferativen erkrankungen und leukämie verbunden sind, und deren verwendungen | |
Ali et al. | Adult‐onset acute myeloid leukaemia in a patient with germline mutation of CBL. | |
WO1998025125A3 (en) | Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus | |
MIZUSHIMA et al. | Association between gene alteration and drug-sensitivity in human lung-carcinoma cell-lines | |
Irizarry et al. | Leveraging naked mole rat (Heterocephalus glaber) comparative genomics to identify canine genes modulating susceptibility to tumorigenesis and cancer phenotypes. | |
Sangatsuda et al. | TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3. 3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS | |
Wozna et al. | The immunological, biochemical and molecular bases of canine senescence and carcinogenesis: a review. | |
MX9701074A (es) | Gen de susceptibilidad al cancer de pecho y ovario enlazado con 17q. | |
AU3925701A (en) | Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |